Stephen Mandel’s Zymeworks ZYME Stock Holding History

Stephen Mandel’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-976,735	Closed	-$28.4M	–	41
2021 Q3	$28.4M	Hold	976,735	–	–	0.1%	37
2021 Q2	$33.9M	Hold	976,735	–	–	0.11%	32
2021 Q1	$30.8M	Hold	976,735	–	–	0.11%	36
2020 Q4	$46.2M	Buy	+976,735	New	+$45.4M	0.17%	39

Other funds holding ZYME

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Stephen Mandel's ZYME Position: Q4 2021 in Review

Stephen Mandel sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 976,735 shares — an estimated $28.4M sold.

Stephen Mandel first reported a position in ZYME in Q4 2020 and held it in 4 quarters. The position peaked at $46.2M in Q4 2020. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

Stephen Mandel reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
Stephen Mandel sold 976,735 Zymeworks shares in Q4 2021, an estimated $28.4M.
Stephen Mandel first reported a position in Zymeworks in Q4 2020 and held it in 4 quarters.
Stephen Mandel's Zymeworks position peaked at $46.2M in Q4 2020.
114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on Lone Pine Capital's 13F filing for Q4 2021, filed 14 Feb 2022.